Search Press releases Keywords From To 18 Feb 2022 Disposal of own shares Read More 11 Feb 2022 Disposal of own shares Read More 4 Feb 2022 Disposals of own shares Read More 4 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Read More 2 Feb 2022 Transparency notification FMR LLC. Read More 2 Feb 2022 UCB Receives Positive CHMP Opinion Recommending Approval of BRIVIACT[®] (brivaracetam) and VIMPAT[®] (lacosamide) in the EU for Partial-Onset Seizures in Pediatric Patients From Two to Four Years Read More Pagination First page Previous page Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
